to examine this hypothesis , placebo or omega-3 pufas as max-epa ( equivalent to 3.2 g of eicosapentaenoic acid and 2.2 g of docosahexaenoic acid daily ) was administered to eight patients with stable coronary artery disease and positive exercise stress test results in a randomized , double-blind , crossover fashion over a 12-week period .
C0015689
omega-3 pufas
C0012968
docosahexaenoic acid